End-of-day quote
Shanghai S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
21.6
CNY
|
+1.89%
|
|
-1.95%
|
-13.25%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
27,171
|
51,603
|
33,307
|
37,585
|
28,359
|
24,599
|
-
|
-
|
Enterprise Value (EV)
1 |
25,784
|
49,252
|
32,838
|
36,233
|
27,369
|
23,179
|
22,743
|
21,790
|
P/E ratio
|
41.5
x
|
48.4
x
|
42.1
x
|
36.3
x
|
24.2
x
|
15.7
x
|
12.9
x
|
11.7
x
|
Yield
|
1.15%
|
1.02%
|
1.19%
|
1.52%
|
1.24%
|
2.71%
|
3.16%
|
2.51%
|
Capitalization / Revenue
|
2.44
x
|
3.54
x
|
1.99
x
|
1.77
x
|
1.16
x
|
0.84
x
|
0.66
x
|
0.55
x
|
EV / Revenue
|
2.31
x
|
3.38
x
|
1.96
x
|
1.71
x
|
1.12
x
|
0.79
x
|
0.61
x
|
0.49
x
|
EV / EBITDA
|
21.3
x
|
27.5
x
|
13.6
x
|
19.2
x
|
12.9
x
|
6.22
x
|
6.45
x
|
4.21
x
|
EV / FCF
|
21.2
x
|
42
x
|
117
x
|
13.1
x
|
19.7
x
|
7.67
x
|
8.24
x
|
6.76
x
|
FCF Yield
|
4.71%
|
2.38%
|
0.86%
|
7.61%
|
5.09%
|
13%
|
12.1%
|
14.8%
|
Price to Book
|
6.65
x
|
9.93
x
|
6.3
x
|
6.24
x
|
4.16
x
|
3.12
x
|
2.72
x
|
2.27
x
|
Nbr of stocks (in thousands)
|
1,078,303
|
1,138,102
|
1,138,968
|
1,138,947
|
1,138,902
|
1,138,846
|
-
|
-
|
Reference price
2 |
25.20
|
45.34
|
29.24
|
33.00
|
24.90
|
21.60
|
21.60
|
21.60
|
Announcement Date
|
4/28/20
|
4/19/21
|
4/27/22
|
4/27/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,141
|
14,583
|
16,759
|
21,248
|
24,531
|
29,453
|
37,245
|
44,550
|
EBITDA
1 |
1,211
|
1,788
|
2,408
|
1,883
|
2,119
|
3,726
|
3,524
|
5,179
|
EBIT
1 |
918.3
|
1,448
|
1,041
|
1,421
|
1,632
|
2,074
|
2,710
|
3,064
|
Operating Margin
|
8.24%
|
9.93%
|
6.21%
|
6.69%
|
6.65%
|
7.04%
|
7.28%
|
6.88%
|
Earnings before Tax (EBT)
1 |
919.5
|
1,446
|
1,044
|
1,415
|
1,628
|
2,167
|
2,636
|
2,913
|
Net income
1 |
702.7
|
1,062
|
791.2
|
1,036
|
1,166
|
1,569
|
1,912
|
2,101
|
Net margin
|
6.31%
|
7.28%
|
4.72%
|
4.87%
|
4.76%
|
5.33%
|
5.13%
|
4.72%
|
EPS
2 |
0.6076
|
0.9375
|
0.6944
|
0.9083
|
1.030
|
1.377
|
1.678
|
1.844
|
Free Cash Flow
1 |
1,214
|
1,174
|
281.7
|
2,759
|
1,392
|
3,023
|
2,758
|
3,222
|
FCF margin
|
10.9%
|
8.05%
|
1.68%
|
12.99%
|
5.67%
|
10.26%
|
7.41%
|
7.23%
|
FCF Conversion (EBITDA)
|
100.27%
|
65.67%
|
11.7%
|
146.56%
|
65.68%
|
81.13%
|
78.27%
|
62.21%
|
FCF Conversion (Net income)
|
172.76%
|
110.52%
|
35.6%
|
266.4%
|
119.32%
|
192.62%
|
144.24%
|
153.37%
|
Dividend per Share
2 |
0.2894
|
0.4630
|
0.3472
|
0.5000
|
0.3100
|
0.5853
|
0.6818
|
0.5422
|
Announcement Date
|
4/28/20
|
4/19/21
|
4/27/22
|
4/27/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,404
|
4,677
|
5,044
|
5,097
|
6,430
|
5,947
|
6,045
|
5,731
|
6,808
|
6,752
|
7,317
|
7,334
|
7,956
|
8,521
|
9,135
|
EBITDA
1 |
-
|
614
|
498.6
|
426.9
|
-
|
-
|
-
|
-
|
-
|
-
|
952.7
|
952.7
|
855.6
|
1,000
|
1,051
|
EBIT
1 |
-41.44
|
492.4
|
438.9
|
291.9
|
197.6
|
684.1
|
576.8
|
371.6
|
27.43
|
570.9
|
623.3
|
505.7
|
413.6
|
599.3
|
632.9
|
Operating Margin
|
-0.94%
|
10.53%
|
8.7%
|
5.73%
|
3.07%
|
11.5%
|
9.54%
|
6.48%
|
0.4%
|
8.45%
|
8.52%
|
6.9%
|
5.2%
|
7.03%
|
6.93%
|
Earnings before Tax (EBT)
1 |
-34.41
|
493.8
|
443.4
|
288.6
|
189
|
679.4
|
547.3
|
363.7
|
37.46
|
572
|
498
|
498
|
424
|
563.5
|
612.5
|
Net income
1 |
-27.1
|
384.2
|
330
|
209.1
|
112.5
|
496.8
|
420.7
|
256.9
|
-7.86
|
398.5
|
356.9
|
356.9
|
315.3
|
403.8
|
438.9
|
Net margin
|
-0.62%
|
8.22%
|
6.54%
|
4.1%
|
1.75%
|
8.35%
|
6.96%
|
4.48%
|
-0.12%
|
5.9%
|
4.88%
|
4.87%
|
3.96%
|
4.74%
|
4.81%
|
EPS
2 |
-0.0347
|
0.3403
|
0.2848
|
0.1833
|
0.1000
|
0.4333
|
0.3767
|
0.2200
|
-
|
0.3500
|
0.3817
|
0.2967
|
0.2769
|
0.3523
|
0.3854
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.3100
|
-
|
-
|
-
|
0.3794
|
Announcement Date
|
4/27/22
|
4/27/22
|
8/29/22
|
10/27/22
|
4/27/23
|
4/27/23
|
8/29/23
|
10/30/23
|
4/28/24
|
4/28/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,387
|
2,351
|
469
|
1,352
|
990
|
1,420
|
1,856
|
2,809
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,214
|
1,174
|
282
|
2,759
|
1,392
|
3,023
|
2,759
|
3,222
|
ROE (net income / shareholders' equity)
|
20.4%
|
22.7%
|
14.6%
|
17.9%
|
18%
|
19.3%
|
22.2%
|
21.6%
|
ROA (Net income/ Total Assets)
|
9.24%
|
10.1%
|
5.33%
|
5.43%
|
-
|
6.2%
|
6.73%
|
7%
|
Assets
1 |
7,605
|
10,502
|
14,834
|
19,088
|
-
|
25,313
|
28,403
|
30,012
|
Book Value Per Share
2 |
3.790
|
4.560
|
4.640
|
5.290
|
5.990
|
6.920
|
7.950
|
9.530
|
Cash Flow per Share
2 |
1.530
|
1.720
|
1.370
|
3.300
|
2.790
|
2.410
|
2.900
|
5.000
|
Capex
1 |
494
|
780
|
1,273
|
997
|
1,782
|
921
|
1,700
|
2,046
|
Capex / Sales
|
4.43%
|
5.35%
|
7.6%
|
4.69%
|
7.26%
|
3.13%
|
4.56%
|
4.59%
|
Announcement Date
|
4/28/20
|
4/19/21
|
4/27/22
|
4/27/23
|
4/28/24
|
-
|
-
|
-
|
Last Close Price
21.6
CNY Average target price
32.99
CNY Spread / Average Target +52.72% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.25% | 3.4B | | -30.56% | 11.21B | | -30.19% | 6.23B | | +7.42% | 6B | | -10.01% | 5.89B | | -0.73% | 4.72B | | +53.60% | 4.32B | | -9.42% | 3.77B | | -5.84% | 3.03B | | -2.58% | 2.78B |
Other Drug Retailers
|